DIER MARDI (EVP and CFO) sold 2.4% of their position (258.00 shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $83.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/12/2025ACC: 0001628280-25-012369
Officer· EVP and CFO
Since Mar 2026
-258.00
Net shares
Net seller
$83.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
258.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−258.00
Price / share
$323.04
Trade value
$83.34K
% of position
2.4%
3/10/2025
10.70K→10.44K
Total
Net shares
−258.00
Net value
-$83.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2025 | S · Sale | −258.00 | $323.04 | $83.34K | 2.4% | 10.70K | 10.44K |
| Total | −258.00 | -$83.34K | ||||||
Derivative Transactions0
No derivative transactions reported